U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H18Br2N4O2.2C2H6O4S
Molecular Weight 722.422
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Dibromopropamidine Diisethionate

SMILES

OCCS(O)(=O)=O.OCCS(O)(=O)=O.NC(=N)C1=CC(Br)=C(OCCCOC2=C(Br)C=C(C=C2)C(N)=N)C=C1

InChI

InChIKey=VFDASNWZZRLEAU-UHFFFAOYSA-N
InChI=1S/C17H18Br2N4O2.2C2H6O4S/c18-12-8-10(16(20)21)2-4-14(12)24-6-1-7-25-15-5-3-11(17(22)23)9-13(15)19;2*3-1-2-7(4,5)6/h2-5,8-9H,1,6-7H2,(H3,20,21)(H3,22,23);2*3H,1-2H2,(H,4,5,6)

HIDE SMILES / InChI
Molecular Formula C2H6O4S
Molecular Weight 126.132
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C17H18Br2N4O2
Molecular Weight 470.158
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including http://www.goldeneyecare.co.uk/assets/Uploads/D52491-TP-GEOPL-UK-14v4-GoldenEye-Ointment-0.15.pdf | https://www.medicines.org.uk/emc/PIL.16474.latest.pdf

Dibrompropamidine isetionate is an antiseptic. Ointment containing dibrompropamidine isetionate is used to treat minor eye or eyelid infections, such as conjunctivitis and blepharitis.

Approval Year

Unknown
149124
Targets

Targets

Primary TargetPharmacologyConditionPotency
Inhibitor
8504
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Approved
8583
BROLENE

Approved Use

Dibrompropamidine isetionate is used for minor infections of the eye or eyelid.
PubMed

PubMed

TitleDatePubMed
Cosmetic contact lens-related Acanthamoeba keratitis.
2009-05
[When the treatment is the problem].
2009-02-12
[Graze with unusual progress].
2009-02-12
Good visual outcome after prompt treatment of acanthamoeba keratitis associated with overnight orthokeratology lens wear.
2007-11
Acanthamoeba keratitis: 2007: a train wreck in slow motion.
2007-09
In vitro effect of diamidines on intracellular polyamines of Acanthamoeba polyphaga.
2001
Studies on the mode of action of dibromopropamidine.
1973-06-01

Sample Use Guides

In Vivo Use Guide
Eye ointment containing dibrompropamidine isethionate 0.15% w/w to the affected eye once or twice each day for at least 2 days
Route of Administration: Topical
In Vitro Use Guide
Dibrompropamidine isethionate, 300 μg/ml in aqueous solution was rapidly bactericidal, killing 99.9% of E. coli 15 TAU cells in 3 min.
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:46:28 GMT 2025
Edited
by admin
on Mon Mar 31 17:46:28 GMT 2025
Record UNII
12Y597MO62
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Dibromopropamidine Diisethionate
INCI  
INCI  
Preferred Name English
4,4'-(1,3-PROPANEDIYLBIS(OXY))BIS(3-BROMO-BENZENECARBOXIMIDAMIDE, BIS(2-HYDROXYETHANESULFONATE)
Common Name English
4,4'-(1,3-PROPANEDIYLBIS(OXY))BIS(3-BROMO-BENZENECARBOXIMIDAMIDE, BIS(2-HYDROXYETHANESULPHONATE)
Common Name English
DIBROMPROPAMIDINE ISETIONATE
MART.   WHO-DD  
Common Name English
Dibrompropamidine isetionate [WHO-DD]
Common Name English
NSC-33424
Code English
DIBROMPROPAMIDINE DIISETIONATE
EP  
Common Name English
DIBROMPROPAMIDINE ISETHIONATE
Common Name English
NSC-528031
Code English
DIBROMPROPAMIDINE DIISETIONATE [EP MONOGRAPH]
Common Name English
DIBROMOPROPAMIDINE ISETHIONATE [MI]
Common Name English
DIBROMPROPAMIDINE DI-ISETHIONATE
Common Name English
Brolene
Common Name English
Dibromopropamidine isethionate
MI  
Common Name English
DIBROMPROPAMIDINE ISETIONATE [MART.]
Common Name English
Code System Code Type Description
ECHA (EC/EINECS)
210-399-5
Created by admin on Mon Mar 31 17:46:28 GMT 2025 , Edited by admin on Mon Mar 31 17:46:28 GMT 2025
PRIMARY
PUBCHEM
16735405
Created by admin on Mon Mar 31 17:46:28 GMT 2025 , Edited by admin on Mon Mar 31 17:46:28 GMT 2025
PRIMARY
SMS_ID
100000092617
Created by admin on Mon Mar 31 17:46:28 GMT 2025 , Edited by admin on Mon Mar 31 17:46:28 GMT 2025
PRIMARY
EVMPD
SUB01662MIG
Created by admin on Mon Mar 31 17:46:28 GMT 2025 , Edited by admin on Mon Mar 31 17:46:28 GMT 2025
PRIMARY
RXCUI
22862
Created by admin on Mon Mar 31 17:46:28 GMT 2025 , Edited by admin on Mon Mar 31 17:46:28 GMT 2025
PRIMARY RxNorm
CAS
614-87-9
Created by admin on Mon Mar 31 17:46:28 GMT 2025 , Edited by admin on Mon Mar 31 17:46:28 GMT 2025
PRIMARY
MERCK INDEX
m4299
Created by admin on Mon Mar 31 17:46:28 GMT 2025 , Edited by admin on Mon Mar 31 17:46:28 GMT 2025
PRIMARY Merck Index
FDA UNII
12Y597MO62
Created by admin on Mon Mar 31 17:46:28 GMT 2025 , Edited by admin on Mon Mar 31 17:46:28 GMT 2025
PRIMARY
MESH
C053597
Created by admin on Mon Mar 31 17:46:28 GMT 2025 , Edited by admin on Mon Mar 31 17:46:28 GMT 2025
PRIMARY
EPA CompTox
DTXSID30210332
Created by admin on Mon Mar 31 17:46:28 GMT 2025 , Edited by admin on Mon Mar 31 17:46:28 GMT 2025
PRIMARY
NSC
528031
Created by admin on Mon Mar 31 17:46:28 GMT 2025 , Edited by admin on Mon Mar 31 17:46:28 GMT 2025
PRIMARY
NSC
33424
Created by admin on Mon Mar 31 17:46:28 GMT 2025 , Edited by admin on Mon Mar 31 17:46:28 GMT 2025
PRIMARY
Related Record Type Details
Structure of Isethionic acid
PARENT -> SALT/SOLVATE
Structure of DIBROMPROPAMIDINE
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of DIBROMPROPAMIDINE
ACTIVE MOIETY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966